Dr. David H. Van Thiel is a distinguished physician-scientist and academic with extensive expertise in hepatology, gastroenterology, internal medicine, and liver transplantation. He has served as a faculty member at Rush University, USA, where he has contributed significantly to clinical research, medical education, and patient care. His research has focused on chronic liver diseases, viral hepatitis, alcohol-related liver disorders, non-alcoholic fatty liver disease (NAFLD), cirrhosis, liver transplantation, and hepatic regeneration. Dr. Van Thiel has authored hundreds of peer-reviewed scientific publications, book chapters, and abstracts, making substantial contributions to the understanding and management of liver diseases. His work has helped advance translational medicine by bridging laboratory discoveries with clinical applications, improving outcomes for patients with complex hepatic disorders.

Dr. Bruce D. Given is a pharmaceutical executive and physician-scientist with extensive experience in drug discovery, clinical development, and biotechnology leadership. He has held senior leadership positions in the biopharmaceutical industry and has contributed significantly to the advancement of innovative therapies for rare, genetic, metabolic, cardiovascular, and infectious diseases. At Arrowhead Pharmaceuticals, USA, Dr. Given has played a key role in the development of RNA interference (RNAi)-based therapeutics, helping translate cutting-edge research into clinical applications. Throughout his career, he has overseen multiple clinical development programs, regulatory strategies, and collaborations that have accelerated the delivery of novel medicines to patients. Dr. Given is widely recognized for his expertise in clinical research, translational medicine, and pharmaceutical innovation.

Dr. Anna Hohler is a distinguished neurologist, educator, and academic leader serving as the Assistant Dean of Academic Affairs at Boston University School of Medicine, USA. She is widely recognized for her expertise in neurology, movement disorders, Parkinson’s disease, medical education, and academic leadership. Dr. Hohler has dedicated her career to advancing neurological care through clinical excellence, innovative research, and physician education. Her research interests include Parkinson’s disease, sleep disorders, neurodegenerative diseases, cognitive disorders, and improving healthcare delivery through evidence-based practice. In addition to her clinical and research contributions, she plays a pivotal role in curriculum development, faculty mentorship, and fostering academic excellence for medical students and trainees. Dr. Hohler has authored numerous peer-reviewed publications, book chapters, and educational resources and is an active participant in national and international scientific conferences.

Dr. Rasha Dosh is an accomplished academic, researcher, and healthcare professional affiliated with Sheffield Hallam University, United Kingdom. Her research focuses on gastroenterology, digestive health, clinical nutrition, metabolic disorders, and translational medical research. Dr. Dosh is actively involved in interdisciplinary research aimed at improving the prevention, diagnosis, and management of gastrointestinal and metabolic diseases through evidence-based clinical practice and innovative healthcare strategies. She has contributed to scientific publications, collaborative research projects, and international conferences, with interests spanning patient-centered care, public health, and medical education. Dr. Dosh is committed to advancing healthcare through research, teaching, and collaboration with multidisciplinary teams.